| 书目名称 | Cancer Chemotherapy by Infusion | | 编辑 | Jacob J. Lokich | | 视频video | http://file.papertrans.cn/222/221075/221075.mp4 | | 图书封面 |  | | 描述 | Chemotherapy for-cancer is in a state of evolution. Because some cancers can now be cured with chemotherapy as a singular modality, this therapy can no longer be viewed as simply a palliative contribution. Chemotherapy has assumed an important role as an adjuvant to other modalities, including both surgery and radiation therapy. For some tumors, the primary application of chemotherapy in a combined modality approach to curative therapy has resulted in the application of less radical surgery while achieving substantial of relatively rare tumors such as cure rates. Nonetheless, with the exception childhood tumors, hematologic malignancies, and testicular cancer, the effec tiveness of chemotherapy in most tumors is severely limited. At the cellular level, greater understanding of the specific mechanism of tumor cell killing and of the phenomenon of drug resistance are elusive, critical ingredients in the improvement of effectiveness in cancer chemotherapy. Prolonging the exposure time of the tumor cell to drugs is a concept that was addressed in the early phases of the development of chemotherapy. How ever, technological limitations inhibited the broader application of chemother ap | | 出版日期 | Book 1987 | | 关键词 | Staging; brain tumors; carcinoma; cell; classification; clinical trial; esophagus; liver; liver tumor; lympho | | 版次 | 1 | | doi | https://doi.org/10.1007/978-94-009-3193-0 | | isbn_softcover | 978-94-010-7932-7 | | isbn_ebook | 978-94-009-3193-0 | | copyright | Precept Press, Inc. 1987 |
The information of publication is updating
|
|
|Archiver|手机版|小黑屋|
派博传思国际
( 京公网安备110108008328)
GMT+8, 2025-8-25 18:11
发表于 2025-3-21 18:13:18
